Early data suggest that the 2024-2025 flu shots have effectively lowered rates of flu hospitalization and outpatient visits ...

The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss ...

The U.S. Food and Drug Administration confirmed on Thursday that a meeting of its independent advisory panel to discuss the ...

Lab tests suggest a strain of the flu virus circulating this season may not be "well-recognized" by the flu vaccine.

“Findings in this report show that vaccination with the 2024–2025 influenza vaccine reduced the likelihood of medically attended influenza and support CDC’s recommendation that all persons aged ≥6 ...

The influenza vaccine for the 2024/2025 season provided moderate protection against influenza A and strong protection against ...

Two long-planned vaccine meetings — one at the US Centers for Disease Control and another at the US Food and Drug ...

So far, fewer than half of US children and older adults have been vaccinated during this year’s high-severity flu season.

So far this season, the vaccine's protection against flu hospitalization was at least 63% for children and at least 41% for adults. These estimates of effectiveness against hospitalization, released ...

The worst flu season the United States has had in more than a decade may have reached its peak, according to data from the US ...

The FDA canceled a meeting of vaccine advisors scheduled for next month to decide the composition of next season's influenza ...

The Food and Drug Administration unexpectedly canceled an annual meeting of its advisers to update next season's influenza vaccines, an adviser on the panel and multiple officials tell CBS News, ...